Tradestie Institutional Equity Comparison Engine

RLAY vs SANA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

RLAY Overall Edge

RLAY Captures Institutional Edge (2โ€“1 Pillars ยท 5โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Relay Therapeutics, Inc. Common Stock (RLAY) driven by superior Momentum & Technical, Options & Structure while SANA counters with relative strength in Growth & Margin. Fundamentally, RLAY trades at N/M Forward P/E with -3094.6% operating margin (-48.3% YoY revenue) versus SANA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, RLAY sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro) against SANA sits in BREAKDOWN (4th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
RLAY N/M vs SANA N/M Fwd P/E
Growth & Margin Winner SANA
Op Margin -3094.6% vs 0.0% ยท YoY -48.3% vs +0.0%
Momentum & Technical Winner RLAY
1Y +167.8% vs -48.6% ยท 52W Pos 74% vs 1%
Options & Structure Winner RLAY
CONSOLIDATION (6th %ile IV) vs BREAKDOWN (4th %ile IV)
RLAY NASDAQ
Relay Therapeutics, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$17.27
-4.53% 1D
Market Cap $4.0B
1M Return +6.08%
1Y Return +167.75%
Forward P/E N/M
Unified AI Score
50.0 / 100 HOLD
Tech 48.0 Fund 55.0 Flow 69.0 Mom 50.0
SANA NASDAQ
Sana Biotechnology, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$1.88
-6.93% 1D
Market Cap $605.3M
1M Return -17.18%
1Y Return -48.63%
Forward P/E N/M
Unified AI Score
44.3 / 100 HOLD
Tech 33.0 Fund 51.0 Flow 66.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: RLAY +167.75% SANA -48.63% Spread: +216.38 pp (RLAY Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
RLAY TTM Op. Margin: -3094.6% SANA TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RLAY vs SANA. Trailing 12-month operating profitability (RLAY -3094.6% vs SANA 0.0%) and valuation multiples (RLAY N/M vs SANA N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: RLAY (5) vs SANA (2)
Institutional Metric RLAY SANA Criterion Row Winner
Market Capitalization Scale $4.0B $605.3M Larger Scale RLAY
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -48.3% +0.0% Higher Growth SANA
Operating Margin (TTM) Profitability -3094.6% 0.0% Higher Margin SANA
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -41.2% -79.5% Higher ROE RLAY
52-Week Range Position Momentum 74% ($6โ€“$21) 1% ($2โ€“$5) Stronger Trend RLAY
Beta / 30D Volatility Risk Regime 1.70ฮฒ ยท 78% Vol 1.82ฮฒ ยท 78% Vol Lower Realized Risk RLAY
Unified Institutional Score Composite Signal 50.0 / 100 (HOLD) 44.3 / 100 (HOLD) Higher Composite RLAY

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full RLAY vs SANA Buy Guide
RLAY CONSOLIDATION
101d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live RLAY Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SANA BREAKDOWN
57d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 4th %ile
IV Regime Compressed (<25th %ile)
Live SANA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither RLAY nor SANA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.